Stemline Therapeutics, Inc.

Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

	The Company
	Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells.

	Platform
	Stemline Therapeutics has developed a Discovery Platform called StemScreen^® to identify novel compounds that target and kill CSCs.

News
&
Events

1/9/2012
Stemline names Eric K. Rowinsky M.D. Chief Medical Officer and Head of R&D

12/12/2011
Stemline to present at Oppenheimer 22nd Annual Healthcare Conference

12/8/2011
Stemline announces presentation of SL-401 efficacy data at ASH 2011